首页>
外国专利>
ADVANCE PROCESS FOR AVASCULAR NECROSIS TREATMENT USING AUTOLOGUS BONE MARROW MESENCHYMAL STEM CELLS (BM MSCS) AND PLATELET RICH PLASMA (PRP) COMBINATION
ADVANCE PROCESS FOR AVASCULAR NECROSIS TREATMENT USING AUTOLOGUS BONE MARROW MESENCHYMAL STEM CELLS (BM MSCS) AND PLATELET RICH PLASMA (PRP) COMBINATION
展开▼
机译：自体标志骨髓间充质干细胞（BM MSCS）和富血小板血浆（PRP）联合治疗血管坏死的进展
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention Advance process for Avascular Necrosis Treatment using Autologous Bone Marrow Mesenchymal Stem Cells (BM MSCs) and Platelet Rich Plasma (PRP) combination makes use of optimal delivery of growth factors and Mesenchymal Stem Cells (MSCs) to treat avascular necrosis. Activated PRP consists of several growth factors and this also works as a biological scaffold. This scaffold in combination with growth factors facilitates neovascularization of AVN bone. In addition, this scaffold helps transplanted MSC to engraft and differentiate in to osteocytes or chondrocytes at the injury site. . This minimally invasive procedure allows the delivery of Platelet Rich Plasma (PRP) and Bone Marrow Mesenchymal Stem Cells (BM MSCs) through a fine needle.
展开▼
